silybin has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, XY; Lang, TQ; Li, YP; Yin, Q; Zhang, PC | 1 |
| Forghani, P; Khorramizadeh, MR; Waller, EK | 1 |
2 other study(ies) available for silybin and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Co-delivery of docetaxel and silibinin using pH-sensitive micelles improves therapy of metastatic breast cancer.
Topics: Acrylic Resins; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Hydrogen-Ion Concentration; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Polyethylene Glycols; Silybin; Silymarin; Structure-Activity Relationship; Taxoids; Tumor Cells, Cultured | 2017 |
Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer.
Topics: Animals; Antioxidants; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, SCID; Myeloid Cells; Random Allocation; Silybin; Silymarin; Xenograft Model Antitumor Assays | 2014 |